▲ 85 r/biotech
Merck halts ph. 2 Alzheimer’s trial after Neuphoria small molecule underwhelms
fiercebiotech.comu/NotGenentech — 2 days ago
▲ 42 r/biotech
Roche orchestrates phase 3 KRAS lung cancer win over Amgen, BMS
fiercebiotech.comu/NotGenentech — 2 days ago
▲ 1 r/biotech
AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
fiercepharma.comu/NotGenentech — 4 days ago
▲ 2 r/biotech
Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
fiercepharma.comu/NotGenentech — 4 days ago
▲ 5 r/biotech
Backed by top-tier VCs, stealthy biotech bags AlzeCure Alzheimer’s asset in $2.2B deal
fiercebiotech.comu/NotGenentech — 4 days ago
▲ 3 r/biotech
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
biospace.comu/NotGenentech — 4 days ago
▲ 6 r/biotech
Theravance, after clinical setbacks, agrees to $929M buyout
biopharmadive.comu/NotGenentech — 4 days ago
▲ 52 r/biotech
US House committee opens investigation into Merck, AbbVie China drug trials
reuters.comu/NotGenentech — 5 days ago
▲ 2 r/biotech
After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
fiercepharma.comu/NotGenentech — 5 days ago
▲ 12 r/biotech
Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
fiercepharma.comu/NotGenentech — 5 days ago
▲ 2 r/biotech
Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE from China’s Metis TechBio
fiercebiotech.comu/NotGenentech — 5 days ago
▲ 38 r/biotech
Federal Judge Allows Whistleblower Lawsuit Against Harvard Over NIH Grants to Proceed
thecrimson.comu/NotGenentech — 7 days ago
▲ 8 r/biotech
Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms
biospace.comu/NotGenentech — 9 days ago
▲ 3 r/biotech
Replimune gets early August decision date for twice-rejected melanoma drug
biospace.comu/NotGenentech — 9 days ago
▲ 2 r/biotech
Remix to go public in reverse merger with once high-flying Passage Bio
biopharmadive.comu/NotGenentech — 9 days ago
▲ 57 r/biotech
Bayer scores landmark victory as Supreme Court overturns Roundup verdict
fiercepharma.comu/NotGenentech — 9 days ago
▲ 10 r/biotech
Biogen ends Apellis research programs, cuts ‘small number’ of roles after $5.6B buyout
fiercebiotech.comu/NotGenentech — 9 days ago
▲ 397 r/biotech
FDA hiring 2,200 people to staff up after last year’s DOGE cuts
biospace.comu/NotGenentech — 10 days ago
▲ 71 r/biotech
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer
biospace.comu/NotGenentech — 10 days ago